Patents by Inventor Kevin RENEHAN

Kevin RENEHAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220079520
    Abstract: An exemplary diffuse optical tomography (DOT) device, can be provided, which can include, for example, a flexible substrate, an optical source(s) configured to generate a plurality of near infrared (NIR) photons disposed on the flexible substrate, and a plurality of detectors disposed on the flexible substrate, wherein each of the detectors can be configured to detect a plurality of backscattered NIR photons from an anatomical structure(s) that can be based on the NIR photons. The flexible substrate can be configured to be applied to an anatomical structure. The detectors can be an array of single photon avalanche diode (SPAD) detectors. The detectors can be configured to measure an arrival time of the backscattered NIR photons. The array can be disposed on a CMOS integrated circuit chip, which can be disposed on the flexible substrate.
    Type: Application
    Filed: November 29, 2021
    Publication date: March 17, 2022
    Inventors: KENNETH L. SHEPARD, SAJJAD MOAZENI, KEVIN RENEHAN
  • Patent number: 10898617
    Abstract: The disclosure concerns various medical devices implemented to provide a nitric oxide rich environment for anti-microbial or anti-thrombogenic benefits. The medical device generally includes a nitric oxide donor material that is contained within a sealed cavity, and a transport medium that defines and captivates the entirety of the cavity, wherein the transport medium is permeable to both water and nitric oxide. As the nitric oxide donor material becomes saturated with water from the surrounding tissue or fluids, nitric oxide is chemically released, and the resulting nitric oxide is communicated through the transport medium to a treatment site for anti-microbial and anti-thrombogenic benefits.
    Type: Grant
    Filed: January 21, 2018
    Date of Patent: January 26, 2021
    Assignee: BIOCREDE INC.
    Inventors: Hao Chen, Kevin Renehan, Kwun Yin Ho, Alexander Wolf
  • Patent number: 10709360
    Abstract: The disclosure concerns medical devices configured to utilize nitric oxide (NO) donor materials to release NO gas upon contact with moisture in order to mitigate bacterial proliferation, coagulation, or a combination thereof, at a site of a biosensor integrated within the medical device. A novel multi-lumen medical device is described, the device having a first lumen for containing the NO donor material and producing the NO gas, and having a second lumen for housing biosensor componentry. A channel between the first and second lumens serves to communicate NO gas from the first lumen to a sensor-volume of the biosensor.
    Type: Grant
    Filed: September 4, 2018
    Date of Patent: July 14, 2020
    Assignee: BIOCREDE INC.
    Inventors: Hao Chen, Alexander Wolf, Kevin Renehan
  • Publication number: 20190069820
    Abstract: The disclosure concerns medical devices configured to utilize nitric oxide (NO) donor materials to release NO gas upon contact with moisture in order to mitigate bacterial proliferation, coagulation, or a combination thereof, at a site of a biosensor integrated within the medical device. A novel multi-lumen medical device is described, the device having a first lumen for containing the NO donor material and producing the NO gas, and having a second lumen for housing biosensor componentry. A channel between the first and second lumens serves to communicate NO gas from the first lumen to a sensor-volume of the biosensor.
    Type: Application
    Filed: September 4, 2018
    Publication date: March 7, 2019
    Applicant: BIOCREDE INC.
    Inventors: Hao CHEN, Alexander WOLF, Kevin RENEHAN
  • Publication number: 20180207323
    Abstract: The disclosure concerns various medical devices implemented to provide a nitric oxide rich environment for anti-microbial or anti-thrombogenic benefits. The medical device generally includes a nitric oxide donor material that is contained within a sealed cavity, and a transport medium that defines and captivates the entirety of the cavity, wherein the transport medium is permeable to both water and nitric oxide. As the nitric oxide donor material becomes saturated with water from the surrounding tissue or fluids, nitric oxide is chemically released, and the resulting nitric oxide is communicated through the transport medium to a treatment site for anti-microbial and anti-thrombogenic benefits.
    Type: Application
    Filed: January 21, 2018
    Publication date: July 26, 2018
    Applicant: BIOCREDE INC.
    Inventors: Hao CHEN, Kevin RENEHAN, Kwun Yin HO, Alexander WOLF